Renaissance Capital LLC Bio N Tech Se Transaction History

Renaissance Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 06, 2022	SELL	$127.65 - $183.11 $273,426 - $392,221	-2,142 Reduced 5.87%	34,334 $4.63 Million
Q2 2022 Jul 11, 2022	BUY	$123.25 - $186.24 $1.38 Million - $2.09 Million	11,209 Added 44.36%	36,476 $5.44 Million
Q1 2022 May 12, 2022	SELL	$126.25 - $231.85 $954,702 - $1.75 Million	-7,562 Reduced 23.03%	25,267 $4.31 Million
Q4 2021 Feb 01, 2022	SELL	$216.64 - $362.52 $1.25 Million - $2.09 Million	-5,755 Reduced 14.92%	32,829 $8.46 Million
Q3 2021 Feb 01, 2022	BUY	$205.93 - $447.23 $7.95 Million - $17.3 Million	38,584 New	38,584 $10.5 Million

360

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $30B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Renaissance Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Capital LLC with notifications on news.